vs
Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $164.7M, roughly 1.4× PTC THERAPEUTICS, INC.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -82.0%, a 86.4% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs -22.7%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $-36.6M). Over the past eight quarters, CSW INDUSTRIALS, INC.'s revenue compounded faster (5.1% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
CSW vs PTCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $233.0M | $164.7M |
| Net Profit | $10.3M | $-135.0M |
| Gross Margin | 39.7% | — |
| Operating Margin | 7.4% | -43.3% |
| Net Margin | 4.4% | -82.0% |
| Revenue YoY | 20.3% | -22.7% |
| Net Profit YoY | -61.9% | -104.8% |
| EPS (diluted) | $0.62 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $233.0M | $164.7M | ||
| Q3 25 | $277.0M | $211.0M | ||
| Q2 25 | $263.6M | $178.9M | ||
| Q1 25 | $230.5M | $1.2B | ||
| Q4 24 | $193.6M | $213.2M | ||
| Q3 24 | $227.9M | $196.8M | ||
| Q2 24 | $226.2M | $186.7M | ||
| Q1 24 | $210.9M | $210.1M |
| Q4 25 | $10.3M | $-135.0M | ||
| Q3 25 | $40.7M | $15.9M | ||
| Q2 25 | $40.9M | $-64.8M | ||
| Q1 25 | $35.1M | $866.6M | ||
| Q4 24 | $26.9M | $-65.9M | ||
| Q3 24 | $36.1M | $-106.7M | ||
| Q2 24 | $38.6M | $-99.2M | ||
| Q1 24 | $31.8M | $-91.6M |
| Q4 25 | 39.7% | — | ||
| Q3 25 | 43.0% | — | ||
| Q2 25 | 43.8% | — | ||
| Q1 25 | 44.2% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 47.5% | — | ||
| Q1 24 | 44.4% | — |
| Q4 25 | 7.4% | -43.3% | ||
| Q3 25 | 20.5% | 1.4% | ||
| Q2 25 | 20.8% | -19.5% | ||
| Q1 25 | 19.5% | 82.5% | ||
| Q4 24 | 15.3% | -76.2% | ||
| Q3 24 | 22.6% | -27.7% | ||
| Q2 24 | 24.3% | -21.5% | ||
| Q1 24 | 21.0% | -21.6% |
| Q4 25 | 4.4% | -82.0% | ||
| Q3 25 | 14.7% | 7.5% | ||
| Q2 25 | 15.5% | -36.3% | ||
| Q1 25 | 15.2% | 73.7% | ||
| Q4 24 | 13.9% | -30.9% | ||
| Q3 24 | 15.8% | -54.2% | ||
| Q2 24 | 17.1% | -53.1% | ||
| Q1 24 | 15.1% | -43.6% |
| Q4 25 | $0.62 | $-1.63 | ||
| Q3 25 | $2.41 | $0.20 | ||
| Q2 25 | $2.43 | $-0.83 | ||
| Q1 25 | $2.05 | $10.04 | ||
| Q4 24 | $1.60 | $-0.85 | ||
| Q3 24 | $2.26 | $-1.39 | ||
| Q2 24 | $2.47 | $-1.29 | ||
| Q1 24 | $2.03 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.2M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $-205.3M |
| Total Assets | $2.3B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.2M | $1.9B | ||
| Q3 25 | $31.5M | $1.7B | ||
| Q2 25 | $38.0M | $2.0B | ||
| Q1 25 | $225.8M | $2.0B | ||
| Q4 24 | $213.8M | $1.1B | ||
| Q3 24 | $273.2M | $1.0B | ||
| Q2 24 | $18.9M | $1.1B | ||
| Q1 24 | $22.2M | $884.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
| Q4 25 | $1.1B | $-205.3M | ||
| Q3 25 | $1.1B | $-155.8M | ||
| Q2 25 | $1.1B | $-206.5M | ||
| Q1 25 | $1.1B | $-185.8M | ||
| Q4 24 | $1.0B | $-1.1B | ||
| Q3 24 | $1.0B | $-1.1B | ||
| Q2 24 | $650.2M | $-980.2M | ||
| Q1 24 | $615.7M | $-893.9M |
| Q4 25 | $2.3B | $2.9B | ||
| Q3 25 | $1.5B | $2.6B | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.4B | $2.7B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.4B | $1.8B | ||
| Q2 24 | $1.1B | $1.9B | ||
| Q1 24 | $1.0B | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | $-34.3M |
| Free Cash FlowOCF − Capex | $22.7M | $-36.6M |
| FCF MarginFCF / Revenue | 9.8% | -22.3% |
| Capex IntensityCapex / Revenue | 2.6% | 1.4% |
| Cash ConversionOCF / Net Profit | 2.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | $162.0M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.9M | $-34.3M | ||
| Q3 25 | $61.8M | $-66.3M | ||
| Q2 25 | $60.6M | $-58.3M | ||
| Q1 25 | $27.3M | $870.1M | ||
| Q4 24 | $11.6M | $-30.0M | ||
| Q3 24 | $66.8M | $-77.0M | ||
| Q2 24 | $62.7M | $-71.5M | ||
| Q1 24 | $22.4M | $70.8M |
| Q4 25 | $22.7M | $-36.6M | ||
| Q3 25 | $58.7M | $-69.7M | ||
| Q2 25 | $57.7M | $-59.6M | ||
| Q1 25 | $22.8M | $868.4M | ||
| Q4 24 | $8.5M | $-33.8M | ||
| Q3 24 | $61.3M | $-77.5M | ||
| Q2 24 | $59.6M | $-78.8M | ||
| Q1 24 | $17.5M | $61.2M |
| Q4 25 | 9.8% | -22.3% | ||
| Q3 25 | 21.2% | -33.1% | ||
| Q2 25 | 21.9% | -33.3% | ||
| Q1 25 | 9.9% | 73.8% | ||
| Q4 24 | 4.4% | -15.8% | ||
| Q3 24 | 26.9% | -39.4% | ||
| Q2 24 | 26.3% | -42.2% | ||
| Q1 24 | 8.3% | 29.1% |
| Q4 25 | 2.6% | 1.4% | ||
| Q3 25 | 1.1% | 1.6% | ||
| Q2 25 | 1.1% | 0.7% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 1.8% | ||
| Q3 24 | 2.4% | 0.3% | ||
| Q2 24 | 1.4% | 4.0% | ||
| Q1 24 | 2.3% | 4.6% |
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.52× | -4.17× | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 0.78× | 1.00× | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
PTCT
Segment breakdown not available.
